BamSEC and AlphaSense Join Forces
Learn More

Rocket Pharmaceuticals Inc.

NASDAQ: RCKT    
Share price (12/27/24): $11.75    
Market cap (12/27/24): $1.071 billion
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.1
from 8-K 44 pages Rocket Pharmaceuticals, Inc. 13,200,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 39 pages Rocket Pharmaceuticals, Inc. 7,812,500 Shares of Common Stock Pre-Funded Warrants to Purchase 3,126,955 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 3 pages Rocket Pharmaceuticals, Inc. Common Stock Amendment No. 1 to Sales Agreement September 12, 2023 Amendment No.1 to Sales Agreement
12/34/56
EX-1.1
from 8-K 40 pages 6,800,000 Shares Rocket Pharmaceuticals, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 42 pages 4,642,858 Shares Rocket Pharmaceuticals, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 38 pages 3,820,000 Shares Rocket Pharmaceuticals, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 39 pages 4,500,000 Shares Rocket Pharmaceuticals, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 38 pages 3,550,000 Shares Rocket Pharmaceuticals, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 37 pages 5,500,000 Shares Rocket Pharmaceuticals, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 48 pages Inotek Pharmaceuticals Corporation 5.75% Convertible Senior Notes Due 2021 Underwriting Agreement
12/34/56
EX-1.2
from S-3 38 pages Inotek Pharmaceuticals Corporation $50,000,000 Sales Agreement
12/34/56
EX-1.1
from S-1/A 40 pages 4,500,000 Inotek Pharmaceuticals Corporation Common Stock Underwriting Agreement
12/34/56
EX-1
from SC 13G 1 page Identification of Members of the Group
12/34/56
EX-1
from SC 13D 2 pages Joint Filing Agreement
12/34/56
EX-1
from SC 13D 4 pages Form of Lock-Up Agreement
12/34/56
EX-1.2
from S-1/A 39 pages Inotek Pharmaceuticals Corporation [ ]% Convertible Senior Notes Due 2020 Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 41 pages [Number of Shares] Inotek Pharmaceuticals Corporation Common Stock Underwriting Agreement
12/34/56